Volume | 514,310 |
|
|||||
News | - | ||||||
Day High | 15.39 | Low High |
|||||
Day Low | 15.075 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
CareDx Inc | CDNA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
15.20 | 15.075 | 15.39 | 15.21 | 15.42 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
9,527 | 514,310 | US$ 15.22 | US$ 7,825,689 | - | 4.80 - 17.03 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:04:36 | priorref | 144 | US$ 15.21 | USD |
CareDx Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
788.07M | 51.78M | - | 280.32M | -190.28M | -3.68 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
CareDx News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CDNA Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 13.64 | 15.615 | 12.90 | 14.07 | 654,216 | 1.57 | 11.51% |
1 Month | 12.63 | 17.03 | 12.5301 | 14.84 | 903,946 | 2.58 | 20.43% |
3 Months | 9.86 | 17.03 | 7.42 | 11.36 | 815,206 | 5.35 | 54.26% |
6 Months | 9.69 | 17.03 | 7.42 | 10.73 | 934,841 | 5.52 | 56.97% |
1 Year | 8.49 | 17.03 | 4.80 | 9.52 | 964,138 | 6.72 | 79.15% |
3 Years | 81.34 | 96.88 | 4.80 | 21.75 | 910,493 | -66.13 | -81.30% |
5 Years | 36.40 | 99.83 | 4.80 | 28.34 | 831,055 | -21.19 | -58.21% |
CareDx Description
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a leading provider of genomics-based information for transplant patients. Its primary operations are in Brisbane, California; Omaha, Nebraska; Fremantle, Australia and Stockholm, Sweden. |